Today, the Australia-based link-in-bio platform Linktree has confirmed its acquisition of competitor Koji from parent company GoMeta, though the exact amount remains undisclosed.
Linktree has announced the cessation of Koji’s link-in-bio product on January 31, 2024. As a gesture, Koji users will receive a three-month trial of Linktree’s Pro plan. However, it remains unclear whether Linktree will facilitate the migration of Koji user data.
Expressing enthusiasm about welcoming Koji users to the Linktree community, the company aims to innovate in the link-in-bio category. While details about Koji’s team joining Linktree were not specified, the statement emphasized Linktree’s commitment to meeting the evolving needs of both existing and new users.
Founded in 2016 by Dmitry Shapiro and Sean Thielen, GoMeta launched Koji as a link-in-bio platform in March 2021, raising $36 million through its parent entity. Koji initially enabled non-technical developers to create “mini apps on the web,” later integrated as templates on the link-in-bio platform. Linktree did not clarify if it plans to adopt these features.
This marks Linktree’s second acquisition in the link-in-bio space in the current year. In June, the company acquired Sequoia-backed link-in-bio startup Bento, with the entire Bento team joining Linktree. The status of Bento’s product post-acquisition remains unaddressed.
Having secured over $165 million in funding and boasting 41 million users globally, Linktree has introduced new integrations with social networks like Threads and Snapchat this year. Additional monetization options, such as “Buy me a gift,” have been implemented, and partnerships with SendOwl allow creators to easily sell various digital content, including audiobooks, videos, images, software, memberships, exclusive events, and courses.
